BEIFA贝发品牌怎么样 申请店铺

我要投票 BEIFA贝发在水性笔行业中的票数:424 更新时间:2025-07-29
BEIFA贝发是哪个国家的品牌?「BEIFA贝发」是 贝发集团股份有限公司 旗下著名品牌。该品牌发源于浙江,由创始人邱智铭在1996期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力BEIFA贝发品牌出海!将品牌入驻外推网,定制BEIFA贝发品牌推广信息,可以显著提高BEIFA贝发产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

BEIFA贝发怎么样

贝发集团股份有限公司始创于1994年,是国内首家打造中国文具供应链运营服务平台的大型集团,主营“文具、文体、文化”(简称“三文”)产品及服务,是中国文具行业的龙头企业,笔类产品产销规模居行业第一,全球第三。

贝发集团是国家高新技术企业、国家创新型企业、全国企事业知识产权示范单位,北京2008年奥运会文具独家供应商等,BEIFA商标是驰名保护,BEIFA产品是中国名牌产品,获得国内外荣誉100多项并承担10余项国家级科技项目。

贝发集团以打造中国文具供应链运营服务平台,建设“四个中心”,即中国文具制造中心、中国文具商品交易中心、中国文具创意设计中心、中国文具分销物流中心为重点,以“抓大带小、扶强带弱”的理念,与行业协会、当地政府共同着力中国“三文”行业公共服务平台建设,汇集中国及亚洲最优质的“三文”名牌供应商,服务于全球零售商、分销商、企事业单位及电子商务平台,有机结合创意设计、研发制造、市场推广、物流配送、供应链融资、信保支持等功能,高效整合各方面优质资源,为平台成员企业提供个性、快速、安全的一站式服务,打造全品类、全球化、全方位、全天候“永不谢幕的三文商品交易会”。

作为文具行业创新平台模式的缔造者,贝发集团定位为成为文具应链服务首选专家,以“2020年成为中国文具供应链第一品牌”为企业愿景、以“为中国文具享誉世界而孜孜以求”为企业使命,将携千家合作伙伴,服务全球。

Founded in 1994, Beifa Group Co., Ltd. is the first large group in China to build a supply chain operation and service platform for stationery in China. It is mainly engaged in "stationery, sports, culture" (referred to as "three culture") products and services. It is a leading enterprise in China's stationery industry, with the production and marketing scale of pen products ranking first in the industry and third in the world. Beifa Group is a national high-tech enterprise, national innovative enterprise, national enterprise and public intellectual property demonstration unit, the exclusive supplier of stationery for the 2008 Beijing Olympic Games, etc. the trademark of Beifa is well-known and protected. Beifa products are China's famous brand products, which have won more than 100 domestic and foreign honors and undertaken more than 10 national science and technology projects. Beifa Group focuses on building China stationery supply chain operation service platform, building "four centers", namely China stationery manufacturing center, China Stationery Commodity Trading Center, China Stationery creative design center, and China stationery distribution and logistics center, with the concept of "focusing on the big, bringing the small, supporting the strong and bringing the weak", and works with industry associations and local governments to focus on the "three culture" industry public in China The construction of service platform integrates the best "three culture" famous brand suppliers in China and Asia, serves global retailers, distributors, enterprises and institutions and e-commerce platforms, organically integrates the functions of creative design, R & D and manufacturing, marketing, logistics and distribution, supply chain financing, and credit guarantee support, efficiently integrates all aspects of high-quality resources, and provides the members of the platform with personalities A fast and safe one-stop service will create an all category, global, all-round and all-weather "three article trade fair that will never end". As the founder of innovation platform mode of stationery industry, Beifa Group is positioned as the first choice expert of stationery response chain service, with the corporate vision of "becoming the first brand of Chinese stationery supply chain in 2020" and the corporate mission of "striving for the world-renowned Chinese stationery", it will bring thousands of partners to serve the world.

本文链接: https://brand.waitui.com/d448a50ed.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

时空科技:实控人终止筹划控制权变更的重大事项,股票明起复牌

36氪获悉,时空科技发布公告,因公司控股股东、实控人宫殿海终止筹划控制权变更的重大事项,公司股票将于2025年7月30日(星期三)开市起复牌。

2小时前

小米集团-W获南向资金净买入16.59亿港元

南向资金今日净买入127.2亿港元。小米集团-W、腾讯控股、阿里巴巴-W分别获净买入16.59亿港元、8.33亿港元、7.53亿港元;泡泡玛特净卖出额居首,金额为3.51亿港元。(第一财经)

2小时前

上海医药:B019新适应症获临床试验批准通知书

36氪获悉,上海医药发布公告,公司下属上药生物治疗自主研发的“B019”收到国家药监局核准签发的《药物临床试验批准通知书》,同意其开展难治性系统性红斑狼疮(简称“新适应症”)的临床试验。

2小时前

湖南天雁:间接控股股东变更为中国长安汽车

36氪获悉,湖南天雁发布公告,经国务院批准,兵器装备集团实施存续分立,分立为兵器装备集团(存续企业)和中国长安汽车(新设企业)。分立前兵器装备集团持有的辰致集团100%股权分立至中国长安汽车,兵器装备集团不再持有湖南天雁股份。本次收购后,中国长安汽车通过辰致集团间接持有湖南天雁3.98亿股股份,占湖南天雁总股本的37.25%,为湖南天雁间接控股股东;国务院国资委仍为湖南天雁实际控制人。

2小时前

智翔金泰:斯乐韦米单抗注射液获药物临床试验批准通知书

36氪获悉,智翔金泰发布公告,公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,公司在研产品斯乐韦米单抗注射液2岁至18岁以下儿童和青少年疑似狂犬病病毒暴露后的被动免疫适应症的临床试验申请获得批准。

2小时前

本页详细列出关于BEIFA贝发的品牌信息,含品牌所属公司介绍,BEIFA贝发所处行业的品牌地位及优势。
咨询